Tuesday, November 12, 2019
- 9:00AM-11:00AM
-
Abstract Number: 2145
Long-term Safety of Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis: Incidence of Severe Infections Through 3 Years (148 Weeks) from 2 Phase 3 Trials
Miscellanous Rheumatic & Inflammatory Disease Poster III: Autoimmune Conditions and Therapies- 9:00AM-11:00AM
-
Abstract Number: 2347
Long-term Survival in Lung Transplantation and Allograft Rejection in Patients with Interstitial Lung Disease Related with Rheumatoid Arthritis: Study from a Single Referral Center
RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 2592
Longitudinal Changes in Health-related Quality of Life in Systemic Sclerosis Treated with Autologous Hematopoietic Stem Cell Transplant Compared to Standard of Care
Systemic Sclerosis & Related Disorders – Clinical Poster III- 9:00AM-11:00AM
-
Abstract Number: 2014
Loss-of-function of the DNA Repair Nuclease MRE11A Induces Mitochondrial Failure and Tissue Inflammation in Rheumatoid Arthritis
RA – Etiology & Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 2413
LOU064: A Highly Selective and Potent Covalent Oral BTK Inhibitor with Promising Pharmacodynamic Efficacy on B Cells for Sjoegren’s Syndrome
Sjögrenʼs Syndrome – Basic & Clinical Science Poster I- 9:00AM-11:00AM
-
Abstract Number: 2531
Low Vitamin D Is Associated with Miscarriage and Preterm Birth in SLE with a U-shaped Relationship
SLE – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2164
Lumbar Spinal Stenosis in Patients with Wild-type Transthyretin Cardiac Amyloidosis
Orthopedics, Low Back Pain, & Rehabilitation Poster – ACR/ARP- 9:00AM-11:00AM
-
Abstract Number: 2312
Lymphoproliferative Disorders in Patients with Rheumatoid Arthritis: Results from Japanese Multi-institutional Study Using Research Electronic Data Capture
RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 2196
Machine Learning Defines the Relationship Between Structural Knee Osteoarthritis and Patient-Important Outcomes: An 8-year Study of 47,858 Knee MRIs from the Osteoarthritis Initiative (OAI)
Osteoarthritis – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 2200
Magnetic Resonance Imaging of Knee Joint Protection Following an Intra-Articular Injection of Lipid-Based Dexamethasone Sodium Phosphate Sustained Release Formulation on Subjects with Knee Osteoarthritis
Osteoarthritis – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 2663
Maintained Benefit in Health-Related Quality of Life of Patients with Giant Cell Arteritis Treated with Tocilizumab Plus Prednisone Tapering: Results from the Open-Label, Long-Term Extension of a Phase 3 Randomized Controlled Trial
Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Giant Cell Arteritis- 9:00AM-11:00AM
-
Abstract Number: L11
Maintenance of Remission Following Dose De-Escalation of Abatacept in Early, MTX-Naïve, ACPA-Positive Patients with RA: Results from a Randomized Phase IIIb Study
Late-Breaking Abstracts ePoster- 9:00AM-11:00AM
-
Abstract Number: 1998
Major Histocompatibility Antigen HLA-DQB1*0601 Is Associated with Rheumatoid Arthritis Among Indians in a Replication Study: Evidence of Gene-Environment Interaction with LPG Stove Use
RA – Etiology & Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 2269
Major Stressors in the Year Prior to Diagnosis Affects RA Characteristics at Presentation and 1 Year
Psychology/Social Science Poster – ARP- 9:00AM-11:00AM
-
Abstract Number: 2584
Management of Cutaneous Manifestations of Lupus Erythematosus: A Systematic Review